Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active Pharmacovigilance.
Parzianello A, Fornasier G, Kiren V, Pigato F, Orzetti S, Zamagni G, Arbo A, Baldo P, Rossi P, Rabusin M, Mascarin M, Trojniak MP. Parzianello A, et al. Among authors: rabusin m. Pharmaceuticals (Basel). 2024 Jan 12;17(1):106. doi: 10.3390/ph17010106. Pharmaceuticals (Basel). 2024. PMID: 38256939 Free PMC article.
No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission.
Dini G, Zecca M, Balduzzi A, Messina C, Masetti R, Fagioli F, Favre C, Rabusin M, Porta F, Biral E, Ripaldi M, Iori AP, Rognoni C, Prete A, Locatelli F; Associazione Italiana Ematologia ed Oncologia Pediatrica–Hematopoietic Stem Cell Transplantation (AIEOP-HSCT) Group. Dini G, et al. Among authors: rabusin m. Blood. 2011 Dec 15;118(25):6683-90. doi: 10.1182/blood-2011-05-354233. Epub 2011 Oct 18. Blood. 2011. PMID: 22010101 Free article.
Impact of Mercaptopurine Metabolites on Disease Outcome in the AIEOP-BFM ALL 2009 Protocol for Acute Lymphoblastic Leukemia.
Franca R, Stocco G, Kiren V, Tessitore A, Fagioli F, Quarello P, Bertorello N, Rizzari C, Colombini A, Bettini LR, Locatelli F, Vinti L, Girardi K, Silvestri D, Valsecchi MG, Decorti G, Rabusin M. Franca R, et al. Among authors: rabusin m. Clin Pharmacol Ther. 2023 Nov;114(5):1082-1092. doi: 10.1002/cpt.3022. Epub 2023 Aug 24. Clin Pharmacol Ther. 2023. PMID: 37550838
Neuroblastic tumors and neurofibromatosis type 1: A retrospective multicenter study in Italy and systematic review of the literature.
Puglisi F, Soma R, Podda M, Vetrella S, Rabusin M, Tropia S, Meli M, Russo G, Sorrentino S, Erminio G, Pulvirenti A, Ruggieri M, Di Cataldo A. Puglisi F, et al. Among authors: rabusin m. Front Pediatr. 2022 Nov 4;10:950911. doi: 10.3389/fped.2022.950911. eCollection 2022. Front Pediatr. 2022. PMID: 36405824 Free PMC article.
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma.
Del Bufalo F, De Angelis B, Caruana I, Del Baldo G, De Ioris MA, Serra A, Mastronuzzi A, Cefalo MG, Pagliara D, Amicucci M, Li Pira G, Leone G, Bertaina V, Sinibaldi M, Di Cecca S, Guercio M, Abbaszadeh Z, Iaffaldano L, Gunetti M, Iacovelli S, Bugianesi R, Macchia S, Algeri M, Merli P, Galaverna F, Abbas R, Garganese MC, Villani MF, Colafati GS, Bonetti F, Rabusin M, Perruccio K, Folsi V, Quintarelli C, Locatelli F; Precision Medicine Team–IRCCS Ospedale Pediatrico Bambino Gesù. Del Bufalo F, et al. Among authors: rabusin m. N Engl J Med. 2023 Apr 6;388(14):1284-1295. doi: 10.1056/NEJMoa2210859. N Engl J Med. 2023. PMID: 37018492
104 results